Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CardioNet nets $47mm through its IPO

Executive Summary

After filing for its initial public offering in August 2007, CardioNet (heart monitors) has finally completed the financing. It sold 3mm common shares priced at $18 each, netting $47mm. Selling shareholders also offered 1.5mm shares. The company announced plans in February to sell 6.6mm shares between $22-24 each.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies